Use of neurokinin antagonists in the treatment of urinary incontinence

Details for Australian Patent Application No. 2004283038 (hide)

Owner Novartis AG

Inventors Weber, Eckhard; Glue, Paul William; McAllister, Kevin Hall

Agent Davies Collison Cave

Pub. Number AU-B-2004283038

PCT Pub. Number WO2005/039563

Priority 60/514,791 27.10.03 US

Filing date 26 October 2004

Wipo publication date 6 May 2005

Acceptance publication date 31 January 2008

International Classifications

A61K 31/165 (2006.01) - having aromatic rings, e.g. colchicine, atenolol, progabide

A61K 31/40 (2006.01) - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

A61K 31/55 (2006.01) - having seven-membered rings, e.g. azelastine, pentylenetetrazole

Event Publications

4 May 2006 PCT application entered the National Phase

  PCT publication WO2005/039563 Priority application(s): WO2005/039563

31 January 2008 Application Accepted

  Published as AU-B-2004283038

29 May 2008 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004283042-Fungicidal mixtures

2004283026-Use of metal tricarbonyl complexes as radiotherapeutic chemotoxic agents